SCHEMBL4306446

SCHEMBL4306446

CCOC(=O)c1cc(OCCCO[Si](C)(C)C(C)(C)C)nn1CC(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.39
ATM Q13315 1/20 0.38
KDM4E B2RXH2 2/20 0.38
XPO1 O14980 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CYP1A2 P05177 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HPGD P15428 1/20 0.37
XBP1 P17861 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KMT2A Q03164 2/20 0.36
CNR1 P21554 1/20 0.36
BRAF P15056 1/20 0.36
GRM5 P41594 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309925 0.88 KMT2A (0.41) XPO1ALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4304978 0.86 KMT2A (0.41) XPO1ALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4304177 0.86 THRB (0.34) ATMKDM4ENPC1RAB9AALDH1A1
SCHEMBL4308163 0.86 KCNN4 (0.33) KDM4ENPC1RAB9AALDH1A1NPSR1
SCHEMBL4302638 0.84 RXFP1 (0.37) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL4308201 0.83 KMT2A (0.41) XPO1ALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4304184 0.82 HRH3 (0.46) LMNANPSR1HPGDKMT2APOLB
SCHEMBL4304477 0.76 TP53BP1 (0.38) ATMKDM4ENPC1RAB9AALDH1A1
SCHEMBL26924584 0.73 ALDH1A1 (0.41) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL4306225 0.72 AVPR1B (0.49) KDM4EALDH1A1NPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009130232-A1 PYRAZOLO [1, 5 -A] PYRAZINE DERIVATIVES AS ANTAGONISTS OF V1B RECEPTORS GLAXO GROUP LIMITED (GB) 2009-10-29 WO disclosed